Using psilocybin in naturalistic settings shows lasting results
Results from the world’s largest study investigating the ‘naturalistic’ use of psilocybin outside of research settings have shown lasting therapeutic benefits.
Carried out by research non-profit Unlimited Sciences and published in Frontiers in Psychiatry, the observational study represents the world’s largest longitudinal dataset on naturalistic psilocybin use to date.
Results reveal the broad therapeutic potential of a single dose of psilocybin in producing lasting improvements in mental health and wellbeing, consistent with the growing body of evidence from clinical trials.
Unlimited Sciences Executive Director and Chief Scientific Officer Matthew X. Lowe, Ph.D.,stated: “Outside of clinical research settings, psilocybin is capable of producing significant and persisting changes in psychological health and wellbeing, such as reductions in anxiety, depression and alcohol misuse.”READ MORE